Kinnate Biopharma Inc

NASDAQ:KNTE   3:09:21 PM EDT
25.03
+0.86 (+3.56%)
Earnings Announcements

Kinnate Biopharma Reports Quarterly Loss Per Share Of $0.49

Published: 08/16/2021 21:14 GMT
Kinnate Biopharma Inc (KNTE) - Kinnate Biopharma Inc. Reports Second Quarter 2021 Financial Results.
Kinnate Biopharma Inc Qtrly Loss per Share $0.49.
Kinnate Biopharma Inc - As of June 30, 2021, Total of Cash and Cash Equivalents and Investments Was $365.1 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.53

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.57

More details on our Analysts Page.